Hikma Pharmaceuticals (HKMPF) Short Interest Ratio & Short Volume → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free HKMPF Stock Alerts $23.37 0.00 (0.00%) (As of 03/27/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort Interest Hikma Pharmaceuticals Short Interest DataCurrent Short Volume1,739,000 sharesPrevious Short Volume1,739,100 sharesChange Vs. Previous Month-0.01%Dollar Volume Sold Short$40.64 millionShort Interest Ratio / Days to Cover8,695.0Last Record DateMarch 15, 2024Outstanding Shares220,230,000 sharesPercentage of Shares Shorted0.79%Today's Trading Volume0 sharesAverage Trading Volume111 sharesToday's Volume Vs. Average0% Short Selling Hikma Pharmaceuticals ? Sign up to receive the latest short interest report for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatHKMPF Short Interest Over TimeHKMPF Days to Cover Over TimeHKMPF Percentage of Float Shorted Over Time Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. Hikma Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20241,739,000 shares $40.64 million 0.0%N/A8695 $23.37 2/29/20241,739,100 shares $46.09 million +0.1%N/A5797 $26.50 2/15/20241,737,700 shares $43.44 million -1.2%N/A2172.1 $25.00 1/15/20241,756,000 shares $43.30 million No ChangeN/A8780 $24.66 12/31/20231,756,000 shares $40.01 million -10.0%N/A2676.8 $22.79 12/15/20231,951,100 shares $43.02 million +0.1%N/A19511 $22.05 Get the Latest News and Ratings for HKMPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/30/20231,948,900 shares $42.95 million +0.3%N/A721.8 $22.04 11/15/20231,944,100 shares $43.28 million +0.5%N/A4860.3 $22.26 10/31/20231,934,300 shares $45.24 million +4.5%N/A4835.8 $23.39 10/15/20231,850,400 shares $46.97 million +5.5%N/A9252 $25.38 9/30/20231,754,100 shares $47.36 million -1.1%N/A17541 $27.00 9/15/20231,774,300 shares $47.91 million -0.1%N/A17743 $27.00 8/31/20231,775,300 shares $47.93 million +0.1%N/A1894.6 $27.00 8/15/20231,774,500 shares $46.94 million +0.1%N/A4436.3 $26.45 7/31/20231,773,300 shares $46.90 million +13.1%N/A479.3 $26.45 7/15/20231,567,500 shares $36.24 million 0.0%N/A1045 $23.12 6/30/20231,567,700 shares $36.21 million -8.0%N/A7838.5 $23.10 6/15/20231,703,900 shares $40.89 million +0.4%N/A8519.5 $24.00 5/31/20231,697,100 shares $39.03 million -0.3%N/A5657 $23.00 5/15/20231,702,000 shares $38.96 million -0.7%N/A17020 $22.89 4/30/20231,714,200 shares $39.72 million +0.4%N/A2857 $23.17 4/15/20231,707,400 shares $35.24 million +11.9%N/A17074 $20.64 3/31/20231,526,500 shares $30.94 million -2.7%N/A1908.1 $20.27 3/15/20231,569,000 shares $32.38 million -0.2%N/A2241.4 $20.64 2/28/20231,571,400 shares $33.20 million +0.3%N/A3928.5 $21.13 2/15/20231,567,000 shares $32.67 million -0.9%N/A3134 $20.85 1/31/20231,580,400 shares $29.82 million +0.6%N/A0 $18.87 1/15/20231,571,500 shares $29.65 million -0.6%N/A0 $18.87 12/30/20221,581,500 shares $29.84 million +0.0%N/A3953.8 $18.87 12/15/20221,581,200 shares $29.84 million -0.1%N/A15812 $18.87 11/30/20221,582,800 shares $22.62 million -0.3%N/A3165.6 $14.29 11/15/20221,588,000 shares $22.69 million +0.3%N/A15880 $14.29 10/31/20221,582,900 shares $22.62 million +0.2%N/A3165.8 $14.29 10/15/20221,579,400 shares $22.55 million +0.4%N/A493.6 $14.28 9/30/20221,572,800 shares $21.64 million +0.2%N/A1966 $13.76 9/15/20221,569,100 shares $23.32 million +114.5%N/A412.9 $14.86 8/31/2022731,700 shares $10.87 million No ChangeN/A385.1 $14.86 8/15/2022731,700 shares $14.20 million +0.5%N/A7317 $19.41 7/31/2022727,800 shares $14.62 million +0.5%N/A7278 $20.09 7/15/2022724,400 shares $14.22 million +54.8%N/A2414.7 $19.63Warning: this could blow your mind (Ad)Buckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…Watch the presentation here HKMPF Short Interest - Frequently Asked Questions What is Hikma Pharmaceuticals' current short interest? Short interest is the volume of Hikma Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 1,739,000 shares of HKMPF short. Learn More on Hikma Pharmaceuticals' current short interest. What is a good short interest ratio for Hikma Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HKMPF shares currently have a short interest ratio of 8,695.0. Learn More on Hikma Pharmaceuticals's short interest ratio. Is Hikma Pharmaceuticals' short interest increasing or decreasing? Hikma Pharmaceuticals saw a drop in short interest in the month of March. As of March 15th, there was short interest totaling 1,739,000 shares, a drop of 0.0% from the previous total of 1,739,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Hikma Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Hikma Pharmaceuticals: Zealand Pharma A/S (0.61%), Aspen Pharmacare Holdings Limited (0.00%), Orion Oyj (0.00%), Amplifon S.p.A. (1.23%), GN Store Nord A/S (0.00%), Sino Biopharmaceutical Limited (0.03%), Nihon Kohden Co. (0.00%), Sysmex Co. (0.00%), Eurofins Scientific SE (0.17%), Shionogi & Co., Ltd. (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Hikma Pharmaceuticals stock? Short selling HKMPF is an investing strategy that aims to generate trading profit from Hikma Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hikma Pharmaceuticals? A short squeeze for Hikma Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HKMPF, which in turn drives the price of the stock up even further. How often is Hikma Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HKMPF, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ZLDPF Short Squeeze APNHY Short Squeeze ORINY Short Squeeze AMFPF Short Squeeze GNNDY Short Squeeze SBMFF Short Squeeze NHNKY Short Squeeze SSMXY Short Squeeze ERFSF Short Squeeze SGIOY Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:HKMPF) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryUrgent: Protect Your Investments from a Chinese InvasionBehind the MarketsSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics